<AD>


<WIRE> Aumake (ASX:AUK) Announces Strategy Update

Aumake, a distributor of Australian goods, proclaimed an update to its strategy with goals to heighten its enterprise in both Chinese and Asian markets.

The company is currently synergizing with Grand Aust International and third-party stores to equip itself for an anticipated influx in tourism.

Aumake (ASX:AUK) specializes in marketing and distributing well-known Australian brands to Asia through online channels.


<WIRE> Nickel Industries (ASX: NIC) Announces Completion of Hengjaya Mine to IMIP Haul Road

Nickel Industries (ASX: NIC) has made an announcement regarding the completion of Hengjaya Mine to IMIP haul road.

The company expects to start the transportation of the first ore down the haul road in August.

Additionally, Nickel Industries (ASX: NIC) stated that the completion of the haul road will allow the mine to rapidly increase the total ore sales to a target of 10 million tonnes per annum.

Nickel Industries is an enterprise that specializes in the mining and distribution of nickel and related products.





<WIRE> Successful Ramp-Up and Commissioning at Po Valley Energy's (ASX:PVE) Podere Maiar-1 Gas Production Facility

Po Valley Energy (ASX:PVE) announced a successful ramp-up and commissioning at its Podere Maiar-1 gas production facility in Italy.

Po Valley Energy and its partners are anticipating initial gas production cash flows before the end of August 2023.

The production at Podere Maiar - 1 has recommenced with forecasted daily production levels of 72,000 standard cubic meters per day (SCM/D).

Po Valley Energy is a company that focuses on the exploration and production of oil and gas in Italy.


<AD>


<WIRE> Memphasys (ASX:MEM) Experiences Significant Jump in Shares Following Distribution Agreement Announcement

Shares of the Australian biotechnology firm, Memphasys (ASX:MEM), have jumped by as much as 25.9% to A$0.017.

If current gains hold, this will be the company’s best day since August 22, 2022.

The firm’s stock has also hit its highest point since July 14.

The increase in stock prices came in the wake of Memphasys' announcement of an exclusive agreement with Vitrolife Japan.

The agreement grants Vitrolife Japan the exclusive right to sell and distribute the Felix™ System in Japan.

Felix™ is an automated device designed for use with single-use cartridges, which serves the purpose of preparing sperm for human IVF procedures.

Despite the recent upturn, Memphasys' stock has seen an overall fall of 3.6% so far this year as of the last close.

Memphasys is a reproductive biotechnology company primarily engaged in creating solutions for human IVF procedures.


<WIRE> Lithium Australia (ASX:LIT) Sees Major Surge in Stock Price following Deal to Form Joint Venture

Lithium Australia’s shares increased by 48.5% to A$0.049, preparing for the best performance since January 19, 2021, if gains persist.

The company announced a deal with Mineral Resources (ASX:MIN) to establish a joint venture and construct a pilot plant.

Under the terms of the agreement, Mineral Resources will be the primary financial backer for the development and operation of the pilot plant in Queensland.

The total budgeted cost for this project is estimated at A$4.5 million.

Lithium Australia also plans to contribute its patented LieNA technology, designed to oversee the plant’s production process.

This announcement has elevated the company’s shares to their highest level since February 7.

Despite this progress, the company’s share price has fallen by 27% this year as of the most recent close.

Lithium Australia is a company that taps into lithium exploration and production to proffer environmentally friendly solutions to the energy storage industry.